Telangana Director of Medical Education issues important measures on clinical trials

Hyderabad: Clinical trials for drugs are legal across the world to increase scientific knowledge and improve health care. However, it should only be done after following stringent norms framed by regulatory authorities with total transparency, said Dr K Ramesh Reddy, Director of Medical Education(DME), on Sunday.
Given recent reports about alleged clinical trials in various government hospitals, the Telangana Director of Medical Education shared an official statement on essential measures taken by the government for patients’ safety during clinical trials.
While issuing a clarification on alleged clinical trials in Nilofuer Hospital, he said, “Only healthy patients, who come forward voluntarily, are included in trials. It is mandatory to conduct enquiries in case of complaints. Same was done in the case of Niloufer Hospital. This is a preventive step for volunteers’ safety. Additionally, individual doctors should not defame institutes for their egos and cause disrepute to the institutes. Disciplinary action will be taken against anyone violating this, as per CCA rules. Any grievance should be addressed to the head of an institution or the Director according to specific guidelines.”
All you need to know about the necessary measures taken by the government for patient safety during clinical trials:
Clinical trials in Niloufer Hospital are allowed by the institutional ethics committee of Osmania Medical College, and they have all necessary permissions. The three-member committee will check all documents to ascertain whether all safety measures were followed. The general public need not panic as any of these drugs is used on regular patients. Only standard drugs procured by TSMSIDC are supplied. These drugs follow all safety measures.
An independent digital media platform that brings you credible news stories and Analysis of current affairs as they unfold.